Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SORT1 | Q99523 | 3/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | KMO | O15229 | 3/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.34 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.33 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5031603 | 0.85 | NR3C2 (0.44) | SORT1DHODHHDAC6NR3C2GRIN3B | |
| SCHEMBL23209358 | 0.74 | DPP4 (0.38) | SORT1DHODHKMOSMARCA2SMARCA4 | |
| SCHEMBL20839296 | 0.73 | HTT (0.39) | SORT1DHODHHDAC6TRPV1 | |
| SCHEMBL28026509 | 0.72 | SMARCA2 (0.38) | SORT1KMOGRM4SMARCA2SMARCA4 | |
| SCHEMBL17700420 | 0.70 | SMN1; SMN2 (0.34) | SORT1DHODHHDAC6NR3C2GRIN3B | |
| SCHEMBL9998439 | 0.68 | CNR2 (0.46) | SORT1DHODH | |
| SCHEMBL11710154 | 0.67 | NOS3 (0.39) | KMO | |
| SCHEMBL28603420 | 0.66 | DHODH (0.40) | SORT1DHODHHDAC6KMOGRIN3B | |
| SCHEMBL24598127 | 0.66 | SMN1; SMN2 (0.47) | — | |
| SCHEMBL1652624 | 0.66 | NPC1 (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957485-A2 | SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | Bayer Healthcare, LLC (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007064931-A2 | SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | BAYER HEALTHCARE LLC (US) | 2007-06-07 | — | — | WO | disclosed |